Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study

por ABDULLAH, MATIN MELLOR, BHAT, AMIT, MOHAMED, AHMAD KAMAL, CHING, FOO YOKE, AHMED, NIDA, GANTOTTI, SANDEEP
Publicado 2016